Li, Bing
Fan, Ke
Zhang, Tonghe
Wu, Zhifeng
Zeng, Siming
Zhao, Mingwei
Ren, Qian
Zheng, Dongping
Wang, Lifei
Liu, Xiaoling
Han, Mei
Song, Yanping
Ye, Jian
Pei, Cheng
Yi, Jinglin
Wang, Xian
Peng, Hui
Zhang, Hong
Zhou, Zhanyu
Liang, Xiaoling
Yu, Fangliang
Wu, Miaoqin
Li, Chaopeng
Lei, Chunling
Hao, Jilong
Tang, Luosheng
Yuan, Huiping
Cai, Shanjun
Li, Qiuming
Zhong, Jingxiang
Li, Suyan
Liu, Lin
Ke, Min
Wang, Jing
Wang, Hui
Zhu, Mengli http://orcid.org/0009-0007-3840-8799
Wang, Zenghua
Yan, Yang
Wang, Feng
Chen, Youxin
Funding for this research was provided by:
Qilu Pharmaceutical Co., Ltd.
Article History
Received: 14 June 2023
Accepted: 11 October 2023
First Online: 21 November 2023
Declarations
:
: Jing Wang, Hui Wang, Mengli Zhu, Zenghua Wang, and Yang Yan are employees of Qilu Pharmaceutical Co., Ltd. Bing Li, Ke Fan, Tonghe Zhang, Zhifeng Wu, Siming Zeng, Mingwei Zhao, Qian Ren, Dongping Zheng, Lifei Wang, Xiaoling Liu, Mei Han, Yanping Song, Jian Ye, Cheng Pei, Jinglin Yi, Xian Wang, Hui Peng, Hong Zhang, Zhanyu Zhou, Xiaoling Liang, Fangliang Yu, Miaoqin Wu, Chaopeng Li, Chunling Lei, Jilong Hao, Luosheng Tang, Huiping Yuan, Shanjun Cai, Qiuming Li, Jingxiang Zhong, Suyan Li, Lin Liu, Min Ke, Feng Wang, and Youxin Chen declare no competing interests.
: The study protocol was approved by the ethics committee in each center (the approval number of the leading center Peking Union Medical College Hospital: KS2021031). The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice. All patients provided written informed consent before participation.